vTv Therapeutics Inc.
A biopharmaceutical company developing treatments for metabolic and inflammatory diseases. The company is working to minimize long-term complications and is currently conducting clinical trials of an orally administered small molecule glucokinase activator for the treatment of type 1 diabetes, as well as type 2 diabetes, psoriasis, and other diseases. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | North Carolina |
Employees | 16 |
Founded | 2015 |
Financials | |
|---|---|
Market Capitalization | 54.76M |
Revenue | 1.00M |
Operating Income | -22.89M |
Operating Margin | -2289.00% |
Net Income | -20.62M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4038 / 5373 |
Sector : Healthcare | 534 / 1144 |
Industry : Biotechnology | 207 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4487 / 5565 |
Sector : Healthcare | 803 / 1182 |
Industry : Biotechnology | 442 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3821 / 5436 |
Sector : Healthcare | 489 / 1164 |
Industry : Biotechnology | 195 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4866 / 5330 |
Sector : Healthcare | 986 / 1174 |
Industry : Biotechnology | 514 / 667 |